Good morning, everyone. Nice to see you again. We hope your weekend was refreshing and relaxing. Now, of course, the routine resumes with all those meetings and deadlines. We share the feeling, of course. To cope, we are brewing the mandatory cup of stimulation. Please join us. And as always, here are a few tidbits to help you along. Hope your day goes well and do stay in touch...
J&J And Bayer's Xarelto Beats Warfarin In Key Study (Bloomberg News)
J&J's Natrecor Doesn't Kill Or Help Heart Patients (Forbes)
Progress On Heart Disease Slows (The Milwaukee Journal-Sentinel)
Genzyme Eyed Takeda As A White Knight (Bloomberg News)
Pfizer Heart Drug Helps Milder Patients (Reuters)
Merck Sets Growth Strategy In India (LiveMint)
Brazil Lures Big Pharma (The Financial Times)
EMA Says Joint API Pilot Successful (InPharma-Technologist)
Judge Upholds Two HRT Victories For Pfizer (Legal Intelligencer)
Boehringer Ingelheim Loan May Be Forgiven (Ames Tribune)